SUPERNUS PHARMACEUTICALS, INC.·4

Feb 23, 4:19 PM ET

Barlow Carrolee 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-19
Transactions
  • Award

    Common Stock

    2022-02-19+4,2229,433 total
  • Disposition to Issuer

    Restricted Stock Units

    2022-02-194,2220 total
    Common Stock (4,222 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
  • [F2]These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022.

Documents

1 file
  • 4
    tm227492-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT